TRADING UPDATES: Brave Bison earnings jump; Aptamer begins Ebola work
8th Jul 2026 13:21
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More
| Price | 0.475p on 10-07-2026 at 13:00:08 |
|---|---|
| Change | 0.00p 0% |
| Buy | 0.50p |
| Sell | 0.45p |
| Last Trade: | Buy 313,559.00 at 0.4875p |
| Day's Volume: | 730,648 |
| Last Close: | 0.475p |
| Open: | 0.475p |
| ISIN: | GB00BNRRP542 |
| Day's Range | 0.475p - 0.475p |
| 52wk Range: | 0.335p - 1.30p |
| Market Capitalisation: | £16.41m |
| VWAP: | 0.487215p |
| Shares in Issue: | 3.46b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Aptamer Group (APTA) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 313,559 | 0.4875p | Ordinary |
12:20:11 - 10-Jul-26 |
| Sell* | 6,752 | 0.455p | Ordinary |
09:53:55 - 10-Jul-26 |
| Buy* | 900 | 0.50p | Ordinary |
09:31:11 - 10-Jul-26 |
| Buy* | 409,437 | 0.4875p | Ordinary |
08:07:57 - 10-Jul-26 |
| Buy* | 1,250 | 0.50p | Ordinary |
15:24:21 - 09-Jul-26 |
| Buy* | 306,064 | 0.4775p | Ordinary |
15:19:08 - 09-Jul-26 |
| Buy* | 10,256 | 0.4875p | Ordinary |
14:52:57 - 09-Jul-26 |
| Buy* | 36,991 | 0.4775p | Ordinary |
14:46:49 - 09-Jul-26 |
| Sell* | 1,000 | 0.455p | Ordinary |
11:20:55 - 09-Jul-26 |
| Buy* | 400,000 | 0.4875p | Ordinary |
10:13:11 - 09-Jul-26 |
Aptamer Group (APTA) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 8th Jul 2026 7:00 am | RNS | Aptamer initiates Ebola diagnostic test programme |
| 25th Jun 2026 7:00 am | RNS | Programme and technical development update |
| 8th Jun 2026 7:00 am | RNS | Rapid testing programme for fortified foods |
| 13th Apr 2026 1:08 pm | RNS | Result of General Meeting |
| 31st Mar 2026 7:00 am | RNS | Result of Retail Offer and Posting of Notice of GM |
| 26th Mar 2026 7:05 am | RNS | Retail Offer to raise up to £0.5 million |
| 26th Mar 2026 7:00 am | RNS | Results of Placing |
| 25th Mar 2026 7:10 am | RNS | Interim Results and Notice of Investor Webinar |
| 25th Mar 2026 7:00 am | RNS | Proposed Placing, Subscription and Retail Offer |
| 18th Mar 2026 7:00 am | RNS | Launch of targeted radiopharmaceutical programme |